Tim J. Hartung

2.2k total citations · 1 hit paper
32 papers, 1.3k citations indexed

About

Tim J. Hartung is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Neurology. According to data from OpenAlex, Tim J. Hartung has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Pediatrics, Perinatology and Child Health and 8 papers in Neurology. Recurrent topics in Tim J. Hartung's work include Cancer survivorship and care (15 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Functional Brain Connectivity Studies (6 papers). Tim J. Hartung is often cited by papers focused on Cancer survivorship and care (15 papers), Childhood Cancer Survivors' Quality of Life (10 papers) and Functional Brain Connectivity Studies (6 papers). Tim J. Hartung collaborates with scholars based in Germany, Denmark and United States. Tim J. Hartung's co-authors include Anja Mehnert, Uwe Koch, Joachim Weis, Holger Schulz, Martin Härter, Monika Keller, Hermann Faller, Sigrun Vehling, Elmar Brähler and Michael Friedrich and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Scientific Reports.

In The Last Decade

Tim J. Hartung

28 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

One in two cancer patients is significantly distressed: Prevalence and indicators of distress

2017 405 citations Anja Mehnert, Tim J. Hartung et al. Psycho-Oncology profile →

Peers

Countries citing papers authored by Tim J. Hartung

Since Specialization

Citations

This map shows the geographic impact of Tim J. Hartung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim J. Hartung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim J. Hartung more than expected).

Fields of papers citing papers by Tim J. Hartung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim J. Hartung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim J. Hartung. The network helps show where Tim J. Hartung may publish in the future.

Co-authorship network of co-authors of Tim J. Hartung

This figure shows the co-authorship network connecting the top 25 collaborators of Tim J. Hartung. A scholar is included among the top collaborators of Tim J. Hartung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim J. Hartung. Tim J. Hartung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neurite orientation dispersion and density imaging in myelin oligodendrocyte glycoprotein antibody-associated disease and neuromyelitis optica spectrum disorders 2025 ·Multiple Sclerosis and Related Disorders ·Qianlan Chen, (unknown), Patrick Schindler, Frederike Cosima Oertel, Tim J. Hartung, (unknown), Claudia Chien, Stefan Hetzer, (unknown), (unknown), Carsten Finke, (unknown), Alexander U. Brandt, (unknown)	0
2	The Pittsburgh Sleep Quality Index (PSQI) Applied to Cancer Patients: Psychometric Properties and Factors Affecting Sleep Quality 2025 ·Cancer Investigation ·Andreas Hinz, Michael Friedrich, Thomas Schulte, Katja Petrowski, Ana N. Tibubos, Tim J. Hartung	0
3	Two‐year impact of COVID‐19: Longitudinal MRI brain changes and neuropsychiatric trajectories 2025 ·Psychiatry and Clinical Neurosciences ·(unknown), (unknown), Ana Sofia Costa, (unknown), Sandro Romanzetti, Stella A. Glasmacher, (unknown), J. Heine, (unknown), (unknown), (unknown), Tim J. Hartung, Christiana Franke, (unknown), Ferdinand Binkofski, Jörg B. Schulz, Carsten Finke, Kathrin Reetz	3
4	Characteristic functional connectome related to Post-COVID-19 syndrome 2024 ·Scientific Reports ·(unknown), Christian Hohenfeld, Ana Sofia Costa, J. Heine, (unknown), Tim J. Hartung, Christiana Franke, Ferdinand Binkofski, Jörg B. Schulz, Carsten Finke, Kathrin Reetz	7
5	MRI findings in autoimmune encephalitis 2024 ·Revue Neurologique ·Tim J. Hartung, Frederik Bartels, Joseph Kuchling, Sonja Krohn, (unknown), (unknown), (unknown), (unknown), Michael Scheel, Carsten Finke	10
6	Eigenvector Centrality Mapping Reveals Volatility of Functional Brain Dynamics in Anti-NMDA Receptor Encephalitis 2024 ·Biological Psychiatry Cognitive Neuroscience and Neuroimaging ·Tim J. Hartung, (unknown), Stephan Krohn, Tommy A.A. Broeders, Harald Prüß, Menno M. Schoonheim, Carsten Finke	1
7	A quantitative multi-parameter mapping protocol standardized for clinical research in multiple sclerosis 2024 ·Scientific Reports ·(unknown), Tim J. Hartung, Qianlan Chen, Stefan Hetzer, Claudia Chien, (unknown), Tanja Schmitz‐Hübsch, Susanna Asseyer, Rebekka Rust, (unknown), (unknown), (unknown), Alexander U. Brandt, Carsten Finke, (unknown)	0
8	Interconnectivity of fear of progression and generalized anxiety – Network analysis among a sample of hematological cancer survivors 2023 ·Supportive Care in Cancer ·(unknown), Katharina Kuba, Heide Götze, Anja Mehnert, Carsten Spitzer, Tim J. Hartung, Peter Esser	3
9	Structural brain changes in patients with post-COVID fatigue: a prospective observational study 2023 ·EClinicalMedicine ·J. Heine, (unknown), Tim J. Hartung, (unknown), Claudia Chien, (unknown), Rebekka Rust, Christian Hohenfeld, (unknown), Ana S.H. Costa, Carmen Scheibenbogen, Judith Bellmann–Strobl, Friedemann Paul, Christiana Franke, Kathrin Reetz, Carsten Finke	60
10	The T1-weighted/T2-weighted ratio as a biomarker of anti-NMDA receptor encephalitis 2023 ·Journal of Neurology Neurosurgery & Psychiatry ·Tim J. Hartung, Graham Cooper, (unknown), (unknown), (unknown), J. Heine, Claudia Chien, Friedemann Paul, Harald Prüß, Carsten Finke	5
11	The German version of the body image scale: Validation and item response analysis in cancer patients 2022 ·Journal of Psychosomatic Research ·Tim J. Hartung, Michael Friedrich, Peter Esser, Anja Mehnert, (unknown), Anne Letsch, Matthias Rose, (unknown)	0
12	COMSKIL: a communication skills training program for medical students 2021 ·SHILAP Revista de lepidopterología ·Claudia Gebhardt, Anja Mehnert, Tim J. Hartung, Anja Zimmermann, Heide Glaesmer, Heide Götze	9
13	Return to Work in Patients with Hematological Cancers 1 Year after Treatment: A Prospective Longitudinal Study 2018 ·Oncology Research and Treatment ·Tim J. Hartung, Leon Sautier, Angela Scherwath, (unknown), Nicolaus Kröger, Uwe Koch, Anja Mehnert	14
14	The Generalized Anxiety Disorder Screener (GAD‐7) and the anxiety module of the Hospital and Depression Scale (HADS‐A) as screening tools for generalized anxiety disorder among cancer patients 2018 ·Psycho-Oncology ·Peter Esser, Tim J. Hartung, Michael Friedrich, Christoffer Johansen, Hans‐Ulrich Wïttchen, Hermann Faller, Uwe Koch, Martin Härter, Monika Keller, Holger Schulz, Karl Wegscheider, Joachim Weis, Anja Mehnert	126
15	The Hospital Anxiety and Depression Scale (HADS) and the 9‐item Patient Health Questionnaire (PHQ‐9) as screening instruments for depression in patients with cancer 2017 ·Cancer ·Tim J. Hartung, Michael Friedrich, Christoffer Johansen, Hans‐Ulrich Wïttchen, (unknown), Uwe Koch, Elmar Brähler, Martin Härter, Monika Keller, Holger Schulz, Karl Wegscheider, Joachim Weis, Anja Mehnert	102
16	The risk of being depressed is significantly higher in cancer patients than in the general population: Prevalence and severity of depressive symptoms across major cancer types 2016 ·European Journal of Cancer ·Tim J. Hartung, Elmar Brähler, Hermann Faller, Martin Härter, Andreas Hinz, Christoffer Johansen, Monika Keller, Uwe Koch, Holger Schulz, Joachim Weis, Anja Mehnert	215
17	Death-Related Anxiety in Patients With Advanced Cancer: Validation of the German Version of the Death and Dying Distress Scale 2016 ·Journal of Pain and Symptom Management ·(unknown), Katharina Scheffold, Michael Friedrich, Tim J. Hartung, Frank Schulz‐Kindermann, Florian Lordick, Georgia Schilling, Christopher Lo, Gary Rodin, Anja Mehnert	36
18	Predictors of early retirement after cancer rehabilitation-a longitudinal study 2016 ·European Journal of Cancer Care ·Anja Mehnert, Jürgen Barth, Mark Gaspar, (unknown), (unknown), (unknown), Michael Friedrich, Tim J. Hartung, D. Berger, Uwe Koch	27
19	Age-related variation and predictors of long-term quality of life in germ cell tumor survivors 2015 ·Urologic Oncology Seminars and Original Investigations ·Tim J. Hartung, Anja Mehnert, Michael Friedrich, Michael Hartmann, Sigrun Vehling, Carsten Bokemeyer, Karin Oechsle	13
20	Psychoonkologische Versorgungsforschung 2015 ·Der Nervenarzt ·Anja Mehnert, Tim J. Hartung	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact